Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Reynolds

Showing results (121-130 of 212) with videos related to

Pageof 22
Sort By:
Pediatric Blood & Cancer|April 26, 2007
Initial testing of the VEGFR inhibitor AZD2171 by the pediatric preclinical testing programJohn M Maris, Joshua Courtright, Peter J Houghton, et al.
Pediatric Blood & Cancer|July 9, 2015
Pilot study of intravenous melphalan combined with continuous infusion L-S,R-buthionine sulfoximine for children with recurrent neuroblastomaClarke P Anderson, Katherine K Matthay, John P Perentesis, et al.
Pediatric Blood & Cancer|May 7, 2009
Initial testing of aplidin by the pediatric pre-clinical testing programChristopher L Morton, Peter J Houghton, Richard Gorlick, et al.
Cancer Chemotherapy and Pharmacology|January 10, 2021
A phase I study of intravenous fenretinide (4-HPR) for patients with malignant solid tumorsJacob S Thomas, Anthony B El-Khoueiry, Barry J Maurer, et al.
Cell Death & Disease|May 16, 2020
MYC transcription activation mediated by OCT4 as a mechanism of resistance to 13-cisRA-mediated differentiation in neuroblastomaSung-Jen Wei, Thinh H Nguyen, In-Hyoung Yang, et al.
Pediatric Blood & Cancer|July 31, 2010
Initial testing (stage 1) of the multi-targeted kinase inhibitor sorafenib by the pediatric preclinical testing programStephen T Keir, John M Maris, Richard Lock, et al.
Pediatric Blood & Cancer|February 8, 2011
Initial testing (stage 1) of the IGF-1 receptor inhibitor BMS-754807 by the pediatric preclinical testing programE Anders Kolb, Richard Gorlick, Richard Lock, et al.
Pediatric Blood & Cancer|May 7, 2009
Initial testing (stage 1) of vorinostat (SAHA) by the pediatric preclinical testing programNino Keshelava, Peter J Houghton, Christopher L Morton, et al.
Pediatric Blood & Cancer|November 5, 2011
Initial testing (stage 1) by the pediatric preclinical testing program of RO4929097, a γ-secretase inhibitor targeting notch signalingE Anders Kolb, Richard Gorlick, Stephen T Keir, et al.
Pediatric Blood & Cancer|October 28, 2016
Initial testing of VS-4718, a novel inhibitor of focal adhesion kinase (FAK), against pediatric tumor models by the Pediatric Preclinical Testing ProgramRaushan T Kurmasheva, Richard Gorlick, E Anders Kolb, et al.
Pageof 22

Showing results (121-130 of 212) with videos related to

Sort By:
Pageof 22
Pediatric Blood & Cancer|April 26, 2007
Initial testing of the VEGFR inhibitor AZD2171 by the pediatric preclinical testing programJohn M Maris, Joshua Courtright, Peter J Houghton, et al.
Pediatric Blood & Cancer|July 9, 2015
Pilot study of intravenous melphalan combined with continuous infusion L-S,R-buthionine sulfoximine for children with recurrent neuroblastomaClarke P Anderson, Katherine K Matthay, John P Perentesis, et al.
Pediatric Blood & Cancer|May 7, 2009
Initial testing of aplidin by the pediatric pre-clinical testing programChristopher L Morton, Peter J Houghton, Richard Gorlick, et al.
Cancer Chemotherapy and Pharmacology|January 10, 2021
A phase I study of intravenous fenretinide (4-HPR) for patients with malignant solid tumorsJacob S Thomas, Anthony B El-Khoueiry, Barry J Maurer, et al.
Cell Death & Disease|May 16, 2020
MYC transcription activation mediated by OCT4 as a mechanism of resistance to 13-cisRA-mediated differentiation in neuroblastomaSung-Jen Wei, Thinh H Nguyen, In-Hyoung Yang, et al.
Pediatric Blood & Cancer|July 31, 2010
Initial testing (stage 1) of the multi-targeted kinase inhibitor sorafenib by the pediatric preclinical testing programStephen T Keir, John M Maris, Richard Lock, et al.
Pediatric Blood & Cancer|February 8, 2011
Initial testing (stage 1) of the IGF-1 receptor inhibitor BMS-754807 by the pediatric preclinical testing programE Anders Kolb, Richard Gorlick, Richard Lock, et al.
Pediatric Blood & Cancer|May 7, 2009
Initial testing (stage 1) of vorinostat (SAHA) by the pediatric preclinical testing programNino Keshelava, Peter J Houghton, Christopher L Morton, et al.
Pediatric Blood & Cancer|November 5, 2011
Initial testing (stage 1) by the pediatric preclinical testing program of RO4929097, a γ-secretase inhibitor targeting notch signalingE Anders Kolb, Richard Gorlick, Stephen T Keir, et al.
Pediatric Blood & Cancer|October 28, 2016
Initial testing of VS-4718, a novel inhibitor of focal adhesion kinase (FAK), against pediatric tumor models by the Pediatric Preclinical Testing ProgramRaushan T Kurmasheva, Richard Gorlick, E Anders Kolb, et al.
Pageof 22